Structural mechanisms of Clostridium difficile pathogenesis
艰难梭菌发病机制的结构机制
基本信息
- 批准号:9916698
- 负责人:
- 金额:$ 39.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-05-15 至 2021-04-30
- 项目状态:已结题
- 来源:
- 关键词:Anaerobic BacteriaAntibodiesApoptosisBacteriaBindingBinding SitesCRISPR/Cas technologyCell physiologyCellsCellular AssayClostridium difficileColonComplexCryo-electron tomographyCrystallizationCytosolDataDevelopmentDiarrheaDiseaseElectron MicroscopyEndosomesEpithelial CellsEventFamilyFluorescenceFundingGenetic VariationGlucosyltransferaseGoalsGuanosine Triphosphate PhosphohydrolasesHomologous ProteinHospitalsHumanHuman poliovirusHybridsHydrophobicityIncidenceIndividualInfectionInflammationIntegration Host FactorsIntoxicationLabelLeadMeasurementMediatingMembraneModelingMolecularMusMutagenesisMutationNADPH OxidaseNecrosisNormal tissue morphologyPathogenesisPathologyPhysiologicalPreventionProductionProteinsPseudomembranous ColitisPublic HealthPublishingReactive Oxygen SpeciesReproduction sporesResearchRoleSeriesSeveritiesStructureTestingTherapeuticTherapeutic InterventionTissuesToxic MegacolonToxinUnited StatesVaccine AntigenVaccinesVariantViral ProteinsVirulence FactorsX-Ray Crystallographyalpha Toxinalpha helixantibiotic-associated diarrheacostcrosslinkcytotoxicitydesignexperimental studyfollow-uphuman diseaseimprovedmouse modelnew therapeutic targetnovel therapeuticspoliovirus receptorprogramspublic health relevancereceptorreceptor mediated endocytosisrhoscaffoldtherapeutic targettool
项目摘要
DESCRIPTION (provided by applicant): Clostridium difficile is a gram-positive, spore-forming anaerobe that infects the colon, causing a range of human disease including diarrhea, pseudomembranous colitis, and toxic megacolon. The incidence, severity, and costs associated with C. difficile infection (CDI) are increasing, making C. difficile a significant public health concern. The principle virulence factors in C. difficile pathogenesis are TcdA and TcdB, two large homologous toxins capable of entering and modifying multiple targets within eukaryotic host cells. This proposal is designed to follow up two important discoveries made in the previous funding cycle, a crystal structure of TcdA and the cellular receptor for TcdB. In Aim 1, we will use the structure of the TcdA delivery domain as a framework for understanding toxin pore formation within the host endosomal membrane. A hybrid approach of electron microscopy, crosslinking, and fluorescence intensity measurements will generate a structural view of the toxin pore. In Aim 2, we will define the interaction of TcdB with its receptor, PVRL3, using a hybrid of electron microscopy, mutagenesis, quantitative binding studies, and X-ray crystallography. In Aim 3, we will evaluate the relevance of the TcdB-PVRL3 interaction in mouse models of intoxication and infection. Results from these aims will provide a molecular understanding of the events that allow toxins access to the host cell and a framework for therapeutic intervention.
描述(由申请方提供):艰难梭菌是一种革兰氏阳性、孢子形成厌氧菌,可感染结肠,引起一系列人类疾病,包括腹泻、伪膜性结肠炎和毒性巨结肠。与C.艰难梭菌感染(CDI)的增加,使C.这是一个重大的公共卫生问题。C.艰难梭菌的致病机制是TcdA和TcdB,这两种大的同源毒素能够进入并修饰真核宿主细胞内的多个靶标。该提案旨在跟进上一个资助周期中的两个重要发现,TcdA的晶体结构和TcdB的细胞受体。在目标1中,我们将使用TcdA递送结构域的结构作为理解宿主内体膜内毒素孔形成的框架。电子显微镜、交联和荧光强度测量的混合方法将产生毒素孔的结构视图。在目标2中,我们将使用电子显微镜、诱变、定量结合研究和X射线晶体学的混合物来定义TcdB与其受体PVRL 3的相互作用。在目的3中,我们将评估TcdB-PVRL 3相互作用在中毒和感染的小鼠模型中的相关性。从这些目标的结果将提供一个分子的理解,允许毒素进入宿主细胞和治疗干预的框架的事件。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dana Borden Lacy其他文献
Dana Borden Lacy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dana Borden Lacy', 18)}}的其他基金
Vanderbilt Antibody and Antigen Discovery for Clostridioides difficile Vaccines
艰难梭菌疫苗的范德比尔特抗体和抗原发现
- 批准号:
10625686 - 财政年份:2023
- 资助金额:
$ 39.43万 - 项目类别:
Project 1: Mucosal toxin subunit immunization as a strategy for C. difficile vaccine development
项目 1:粘膜毒素亚基免疫作为艰难梭菌疫苗开发的策略
- 批准号:
10625692 - 财政年份:2023
- 资助金额:
$ 39.43万 - 项目类别:
12th International Conference on the Molecular Biology and Pathogenesis of Clostridia (Clostpath 12)
第十二届梭状芽胞杆菌分子生物学和发病机制国际会议 (Clostridia 12)
- 批准号:
10318438 - 财政年份:2021
- 资助金额:
$ 39.43万 - 项目类别:
The role of toxins in Clostridium difficile infection pathogenesis
毒素在艰难梭菌感染发病机制中的作用
- 批准号:
10412917 - 财政年份:2015
- 资助金额:
$ 39.43万 - 项目类别:
Pre-clinical evaluation of Clostridium difficile toxin inhibitors
艰难梭菌毒素抑制剂的临床前评价
- 批准号:
9487905 - 财政年份:2015
- 资助金额:
$ 39.43万 - 项目类别:
The role of toxins in Clostridium difficile infection pathogenesis
毒素在艰难梭菌感染发病机制中的作用
- 批准号:
9889242 - 财政年份:2015
- 资助金额:
$ 39.43万 - 项目类别:
The role of toxins in Clostridium difficile infection pathogenesis
毒素在艰难梭菌感染发病机制中的作用
- 批准号:
10516088 - 财政年份:2015
- 资助金额:
$ 39.43万 - 项目类别:
Structural mechanisms of Clostridium difficile pathogenesis
艰难梭菌发病机制的结构机制
- 批准号:
9212765 - 财政年份:2011
- 资助金额:
$ 39.43万 - 项目类别:
Structural Mechanisms of Clostridioides difficile pathogenesis
艰难梭菌发病机制的结构机制
- 批准号:
10620653 - 财政年份:2011
- 资助金额:
$ 39.43万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 39.43万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 39.43万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 39.43万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 39.43万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 39.43万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 39.43万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 39.43万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 39.43万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 39.43万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 39.43万 - 项目类别: